Counsel to Wilmington Trust

Orexigen Therapeutics

Representation of Wilmington Trust, as agent, with respect to debtor in possession credit facilities extended to Orexigen Therapeutics, a biopharmaceutical company focused on the treatment of obesity and the commercialization of a pharmaceutical drug for chronic weight management, in its Chapter 11 case pending in Wilmington, Delaware.

Email Disclaimer